{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:18:24Z","timestamp":1773011904094,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1245\/s10434-021-10776-7","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T15:48:51Z","timestamp":1633103331000},"page":"1165-1170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management"],"prefix":"10.1245","volume":"29","author":[{"given":"Giulio","family":"Ricotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Maulard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Candiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Genestie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Pautier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Mangili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Morice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Gouy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"10776_CR1","unstructured":"Kurman RJ, Carcangiu ML, Simon Herrington C, Young RH. WHO Classification of Tumours of Female Reproductive Organs. Vol 4th. 5th ed.; 2020."},{"issue":"6","key":"10776_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/IGC.0b013e3182534acf","volume":"22","author":"C Uzan","year":"2012","unstructured":"Uzan C, Dufeu-Lefebvre M, Fauvet R, et al. Management and prognosis of clear cell borderline ovarian tumor. Int J Gynecol Cancer. 2012;22(6):993\u20139. https:\/\/doi.org\/10.1097\/IGC.0b013e3182534acf.","journal-title":"Int J Gynecol Cancer."},{"issue":"12","key":"10776_CR3","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1002\/1097-0142(19851215)56:12<2922::aid-cncr2820561233>3.0.co;2-l","volume":"56","author":"DA Bell","year":"1985","unstructured":"Bell DA, Scully RE. Benign and borderline clear cell adenofibromas of the ovary. Cancer. 1985;56(12):2922\u201331. https:\/\/doi.org\/10.1002\/1097-0142(19851215)56:12%3c2922::aid-cncr2820561233%3e3.0.co;2-l.","journal-title":"Cancer."},{"key":"10776_CR4","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2012.20","author":"E Cakir","year":"2012","unstructured":"Cakir E, Aydin E, Durmus NI, Samdanci E, Sahin N, Nurkabul Z. Primary ovarian clear cell adenofibroma of borderline malignancy. Oman Med J. 2012. https:\/\/doi.org\/10.5001\/omj.2012.20.","journal-title":"Oman Med J."},{"issue":"4","key":"10776_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/mco.2021.2237","volume":"14","author":"T Hada","year":"2021","unstructured":"Hada T, Miyamoto M, Ishibashi H, et al. Clear cell borderline tumor without fibromatous component: pathological and literature review and report of two cases. Mol Clin Oncol. 2021;14(4):75. https:\/\/doi.org\/10.3892\/mco.2021.2237.","journal-title":"Mol Clin Oncol."},{"issue":"1","key":"10776_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0020-7292(96)02674-4","volume":"54","author":"H Ji","year":"1996","unstructured":"Ji H, Yliskoski M, Anttila M, Syrj\u00e4nen K, Saarikoski S. Management of stage-I borderline ovarian tumors. Int J Gynaecol Obstet. 1996;54(1):37\u201344. https:\/\/doi.org\/10.1016\/0020-7292(96)02674-4.","journal-title":"Int J Gynaecol Obstet."},{"key":"10776_CR7","doi-asserted-by":"publisher","unstructured":"Kaern J, Trop\u00e9 CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer. 1993;71(5):1810-1820. https:\/\/doi.org\/10.1002\/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v","DOI":"10.1002\/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v"},{"issue":"6","key":"10776_CR8","first-page":"729","volume":"54","author":"GF Kao","year":"1979","unstructured":"Kao GF, Norris HJ. Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types. Obstet Gynecol. 1979;54(6):729\u201336.","journal-title":"Obstet Gynecol."},{"issue":"1","key":"10776_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/modpathol.3800492","volume":"19","author":"N Kato","year":"2006","unstructured":"Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol. 2006;19(1):83\u20139. https:\/\/doi.org\/10.1038\/modpathol.3800492.","journal-title":"Mod Pathol."},{"issue":"2","key":"10776_CR10","first-page":"87","volume":"38","author":"Y Katsube","year":"1989","unstructured":"Katsube Y, Fujiwara H, Tanioka Y, Imajo M, Fujiwara A. Ovarian clear cell adenofibroma of borderline malignancy. A case report. Hiroshima J Med Sci. 1989;38(2):87\u201390.","journal-title":"Hiroshima J Med Sci."},{"key":"10776_CR11","doi-asserted-by":"publisher","unstructured":"Kleebkaow P, Aue-aungkul A, Temtanakitpaisan A, Kietpeerakool C. Borderline clear cell adenofibroma of the ovary. Case Rep Pathol. 2017; doi: https:\/\/doi.org\/10.1155\/2017\/3860107","DOI":"10.1155\/2017\/3860107"},{"issue":"3","key":"10776_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1658-3876(10)50026-8","volume":"3","author":"J-L Liu","year":"2010","unstructured":"Liu J-L, Chu P-Y, Yeh K-T, Huang R-H. Borderline clear cell adenofibroma with extensive hemorrhagic necrosis. Hematol Oncol Stem Cell Ther. 2010;3(3):158\u201360. https:\/\/doi.org\/10.1016\/S1658-3876(10)50026-8.","journal-title":"Hematol Oncol Stem Cell Ther."},{"issue":"5","key":"10776_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1447-0756.2010.01373.x","volume":"37","author":"K Momotani","year":"2011","unstructured":"Momotani K, Tanaka T, Iwai E, Kanda T, Munakata S, Ohmichi M. Ovarian clear cell adenofibromatous tumor of borderline malignancy associated with high levels of carbohydrate antigen 19\u20139. J Obstet Gynaecol Res. 2011;37(5):472\u20137. https:\/\/doi.org\/10.1111\/j.1447-0756.2010.01373.x.","journal-title":"J Obstet Gynaecol Res."},{"key":"10776_CR14","doi-asserted-by":"publisher","unstructured":"Roth LM, Langley FA, Fox H, Wheeler JE, Czernobilsky B. Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer. 1984;53(5):1156-1163. https:\/\/doi.org\/10.1002\/1097-0142(19840301)53:5<1156::AID-CNCR2820530522>3.0.CO;2-2","DOI":"10.1002\/1097-0142(19840301)53:5<1156::AID-CNCR2820530522>3.0.CO;2-2"},{"issue":"3","key":"10776_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ygyno.2005.12.039","volume":"101","author":"A Suzuki","year":"2006","unstructured":"Suzuki A, Shiozawa T, Mori A, Kimura K, Konishi I. Cystic clear cell tumor of borderline malignancy of the ovary lacking fibromatous components: report of two cases and a possible new histological subtype. Gynecol Oncol. 2006;101(3):540\u20134. https:\/\/doi.org\/10.1016\/j.ygyno.2005.12.039.","journal-title":"Gynecol Oncol."},{"issue":"2","key":"10776_CR16","first-page":"87","volume":"4","author":"SM Vasenwala","year":"2013","unstructured":"Vasenwala SM, Ansari HA, Haider N, Rehman S, Khan T. Atypical proliferating clear cell adenofibroma of the ovary: a case report. Middle East J Cancer. 2013;4(2):87\u201390.","journal-title":"Middle East J Cancer."},{"issue":"2","key":"10776_CR17","first-page":"230","volume":"33","author":"T Vasilakaki","year":"2012","unstructured":"Vasilakaki T, Skafida E, Arkoumani E, Grammatoglou X, Firfiris N, Manoloudaki K. Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report. Eur J Gynaecol Oncol. 2012;33(2):230\u20132.","journal-title":"Eur J Gynaecol Oncol."},{"key":"10776_CR18","doi-asserted-by":"publisher","unstructured":"Vo TM, Duong KA, Tran LTH, Bui TC. Recurrence rate and associated factors of borderline ovarian tumors in the south of Vietnam. J Obstet Gynaecol Res. 2019;45(10): 2055-2061. https:\/\/doi.org\/10.1111\/jog.14072","DOI":"10.1111\/jog.14072"},{"issue":"2","key":"10776_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1525-1438.2007.00864.x","volume":"17","author":"HF Wong","year":"2007","unstructured":"Wong HF, Low JJH, Chua Y, Busmanis I, Tay EH, Ho TH. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer. 2007;17(2):342\u20139. https:\/\/doi.org\/10.1111\/j.1525-1438.2007.00864.x.","journal-title":"Int J Gynecol Cancer."},{"key":"10776_CR20","doi-asserted-by":"publisher","unstructured":"Zhao C, Wu LS-F, Barner R. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer. 2011;2:94-106. https:\/\/doi.org\/10.7150\/jca.2.94","DOI":"10.7150\/jca.2.94"},{"issue":"5","key":"10776_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/AOG.0000000000003507","volume":"134","author":"K Matsuo","year":"2019","unstructured":"Matsuo K, Machida H, Yamagami W, et al. Intraoperative capsule rupture, postoperative chemotherapy, and survival of women with stage I epithelial ovarian cancer. Obstet Gynecol. 2019;134(5):1017\u201326. https:\/\/doi.org\/10.1097\/AOG.0000000000003507.","journal-title":"Obstet Gynecol."},{"key":"10776_CR22","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-09879-y","author":"G Ricotta","year":"2021","unstructured":"Ricotta G, Maulard A, Genestie C, et al. Brenner borderline ovarian tumor: a case series and literature review. Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1245\/s10434-021-09879-y.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10776-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10776-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10776-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T15:15:59Z","timestamp":1641222959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10776-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10776"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10776-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"25 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}